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Abstract 
Specific language impairment (SLI) is diagnosed when a child has major problems in 
learning to talk and/or understand language, despite showing normal development in 
all other areas (Bishop, 2006). In this chapter we will discuss recent research on the 
genetics of SLI. We will introduce methods used in human genetics and describe 
studies in which these methods were applied. We will discuss how emerging genetic 
technologies may be used to investigate the molecular basis of neurodevelopmental 
disorders and elucidate the biological mechanisms influencing linguistic traits. 
Basic concepts in genetics 
We each carry two sets of 23 chromosomes, one set from each of our parents. These 
consist of two copies of chromosomes 1-22 and two sex chromosomes (females carry 
two X chromosomes; males have one X chromosome and one Y chromosome). A 
gene is a physical stretch of DNA sequence that holds the instructions for the 
synthesis of a functional molecule, usually a protein. Each gene may have several 
variants in a population, called alleles. As we have two copies of each chromosome 
(chromosomes 1-22), for any given variant, we can carry two identical alleles (in 
which case we would be homozygous for said allele), or two different alleles (in 
which case we would be heterozygous). 
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Different alleles in a given gene do not necessarily have functional differences: the 
proteins they encode can be identical, or so similar as to have only subtle, functional 
differences. However, sometimes, an allele can lead to a dysfunctional protein, to 
various extents, and this may result in a disease or a disorder. A disorder is called 
recessive when it only affects people who carry two deleterious alleles in the relevant 
gene (or one, when the individual does not carry another allele), or dominant, if one 
deleterious allele is enough to cause it. In contrast, many common disorders, 
including SLI, are complex disorders. A complex disorder involves chance 
combinations of functional, but subtly different, alleles which combine across relevant 
biological pathways and interact with environmental factors. Different combinations 
confer different risks of developing the disorder. The inheritance pattern of complex 
disorders cannot be classified as dominant or recessive. 
During the creation of the sex cells, homologous chromosomes (i.e., a pair of 
chromosomes of the same type) cross-over and exchange DNA between them (a 
process called recombination), so that when one of them is passed onto the child, it is 
not identical to either of the copies the parent has. Instead, the chromosomes that are 
passed on consist of mosaics of randomly defined “parental blocks”. The probability 
of two ancestral alleles that are on the same chromosome being inherited together 
depends upon the physical distance between them. The closer the genes (or, indeed 
any DNA features) are, the less likely they are to be separated by a cross-over. 
Traditional linkage-based methods of identifying disease-causing genes (discussed 
below) use information on recombination events which occurred in the pedigree in 
order to assess linkage. 
Investigating the Heritability of SLI 
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Before genetic studies of SLI can be performed, one must first evaluate its heritability 
using familial aggregation and twin studies. Familial aggregation studies compare the 
incidence of a disorder in families containing an affected proband (the individual 
through whom the family was identified) with that in control families. However, 
familial aggregation studies alone cannot exclude environmental factors. This detail 
requires twin studies. In a twin study, the incidence of disorder in identical co-twins 
of probands (monozygotic (MZ) twin concordance) is compared with that in non-
identical co-twins of probands (dizygotic (DZ) twin concordance). MZ twins are 
assumed to be 100% genetically similar, while DZ twins are assumed to be 50% 
similar. Thus, under the assumption that both twin types have a shared environment, if 
the MZ concordance is significantly higher than the DZ concordance, we can 
conclude that the disorder has a genetic component. Stromswold (1998 and 2001) 
reviewed several familial aggregation and twin studies of SLI and concluded that 
language disorders have a strong genetic component. 
Methods in human genetics 
If a disorder has a genetic component, the next step is to look for the contributory 
genes. We will discuss two traditional approaches to gene identification: linkage and 
association, and follow up with information on newer approaches. Both linkage and 
association methods involve the use of genetic markers, of which there are various 
kinds (e.g. microsatellites and Single-Nucleotide Polymorphisms (SNPs)). Markers 
provide points of reference in the DNA sequence allowing the tracking of parental 
blocks between individuals, and the identification of the genetic signature of an 
individual. 
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Linkage analyses aim to identify chromosome regions that co-segregate with a 
disorder within family units. Linkage methods can be divided into parametric and 
non-parametric approaches. Parametric analyses are more powerful, but require the 
specification of a genetic model of the disease. This includes the inheritance pattern 
(e.g. whether the disease is recessive or dominant), the expected allele frequencies in 
the population, and the penetrance, that is, the probability of expressing a trait (the 
phenotype) given the set of alleles a person has (the genotype) at a given position on 
the chromosome (locus). When these parameters are unknown, which is often the case 
with complex disorders, non-parametric linkage analyses provide an alternative. 
Results of linkage analyses are reported as Logarithm Of Odds (LOD) scores. The 
LOD was originally formulated as a function of the recombination frequency (which 
is correlated with the distance between the marker and the conditional place of the 
disease-causing gene) and was defined as the base-10 logarithm of the ratio between 
the probability of obtaining the observed data (in terms of the number of 
recombination events detected in the pedigree) assuming linkage at a distance defined 
by r and the probability of obtaining the data assuming no linkage. However, there are 
different ways to calculate LOD scores depending on the test used. The higher the 
LOD score, the more likely it is that the disease-causing gene is located near the 
marker, at a distance correlated with r in the tested hypothesis. Thus, LOD scores can 
be maximized over r to produce a maximum LOD score for each marker (i.e. one 
could test linkage at different distances from each marker to find the distance which 
would give the highest LOD score). A LOD score of 3 is usually required to claim 
significant linkage, but a higher score may be required, depending on the number of 
markers tested and the type of analysis used. Lower LOD scores (~2) are sometimes 
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reported as suggestive linkage. For a review of linkage methods, see Teare & Barrett 
(2005). 
In an association study, one looks for a direct statistical correlation between a marker 
allele and a disease in a population (assuming that the disease is caused by the marker 
itself or a variant close to it). These days, case-control association cohorts usually 
consist of large numbers (thousands) of unrelated cases and controls. However, some 
association methods have been developed for family-based studies. Results of 
association studies are usually P values, or –log10(P), when they are plotted, indicating 
whether a certain marker allele is significantly more frequent in cases than controls or 
vice versa. Association significance thresholds depend on the number of markers 
tested: as the number of markers increases, the required number of tests increases and 
the significance threshold becomes more stringent. Genome-wide association studies 
(GWAS) can involve in excess of a million markers, and therefore the accepted 
significance threshold is 5×10-8. In general, association studies require a higher 
density of markers than linkage studies, but they allow a better resolution of the 
identified chromosome segments. For a review of association studies for complex 
traits, see McCarthy et al. (2008). 
Whereas the methods described above use genetic markers to locate disease-causing 
genes, newer technologies allow researchers to obtain the sequence of a person’s 
entire genome. A whole-genome sequence can provide much more information about 
variants that may be influencing a certain trait or increase the risk of having a 
disorder. In fact, an ambitious project called the “1000 Genomes Project” aims to 
produce a catalog of most of the genetic variants with a frequency of at least 1% in 
several human populations studied (1000 Genomes Project Consortium, 2012). Such 
information may have many applications. It could be used, for example, to obtain 
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frequencies of genetic variants in the general population, which can then be compared 
against a sample of individuals affected by some disorder. These data may also be 
used to find statistical correlations between different alleles at specific locations in the 
genome (i.e. the patterns in which they co-occur in different populations), which can 
increase the number of markers to be used in association studies in which only some 
of these genetic markers have been genotyped. That said, genome-wide sequencing 
may at times provide so much information that it becomes difficult to find the cause 
of a genetic disorder. Therefore, another approach, called exome sequencing, may be 
more appropriate in some studies. Exome sequencing entails sequencing only the 
parts of the genomes that contain genes (which make up about 1% of the genome). 
Apart from the fact that it is cheaper to sequence only the exome, compared with the 
entire genome, the information obtained through exome sequencing is more specific, 
as variants detected through exome sequencing (especially if they are in the coding 
regions of genes) may have a more substantial effect on the gene in which they are 
found. It is, therefore, a good method for identifying rare mutations that may be 
deleterious, as opposed to common variants that are used in association studies. 
The next sections will discuss applications of the above methods to the study of the 
genetics of SLI. 
Linkage on chromosomes 16 and 19 
A study by the SLI Consortium (SLIC) (2002) included 98 nuclear families 
(consisting of a father, a mother, and their children), each with at least one child 
affected by SLI, and used non-parametric sib (sibling) pair methods. The children 
were assessed using the Clinical Evaluation of Language Fundamentals (CELF-R), 
the Wechsler Scales of Intelligence (WISC) and Non-Word Repetition (NWR). All 
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probands had Expressive and Receptive Language Scores (ELS and RLS, obtained 
from CELF-R) >1.5 standard deviations (SD) below the normative mean for their 
chronological age and a Performance IQ (PIQ) of >80. For any given marker, sib-
pairs are expected to share 0, 1 or 2 parental alleles with probabilities of 25%, 50% 
and 25%, respectively. However, if both sibs in a given pair are affected by the same 
disorder that is directly caused by a single gene, then the same ancestral chromosome 
region containing the disease-causing allele will always be shared between them. 
Thus, by identifying regions of the genome in which affected sib-pairs show increased 
similarity, we can narrow the search for candidate genes. In the case of complex 
disorders, we expect the regions containing major contributory genes to be shared 
between some affected sib-pairs, and this can be assessed statistically. The SLIC 
study (2002) did not use pairs of affected siblings, but instead performed quantitative 
analyses known as Haseman-Elston (HE) (Haseman & Elston, 1972) and Variance-
Components (VC) methods (Pratt et al., 2000). The HE method implements a 
regression of the squared phenotype differences on the estimated IBD sharing 
(Identity By Descent – the property of two alleles being identical copies of the same 
ancestral allele) for a given sib-pair. The hypothesis is that if a marker is close to a 
gene influencing the trait, then there should be an inverse relation between the sib-pair 
trait differences and the IBD sharing at the marker locus (Haseman & Elston, 1972). 
The VC method separates the trait variability between siblings into a major gene 
variance component, a background genetic variance component, and an 
environmental variance component. It is a model-based method that uses family data 
and compares the likelihood of two models: one in which there is a major gene 
component and another without this effect. At a marker which is close to the gene 
influencing the trait, the first model will be most likely. In SLIC (2002), two 
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significant linkage regions were found: one on chromosome 16 (designated SLI1) 
with NWR (maximum LOD score of 3.55, HE), and another on chromosome 19 
(designated SLI2) with ELS (maximum LOD score of 3.55, HE). 
In their next study, SLIC (2004) increased their sample size to 184 families and 
looked for linkage in the regions previously implicated. They replicated the linkage 
between chromosome 16 and NWR performance, with a maximum LOD score of 
7.46, using the combined sample, confirming the validity of the previous result. The 
linkage on chromosome 19 also replicated, but was linked to different traits: in one 
wave (the 2002 cohort) the trait was ELS, in the second wave (the 2004 sample) it 
was NWR. The maximum LOD score on chromosome 19 with NWR, taking into 
account both samples, was 1.4 (HE). 
Further evidence for the linkage region on chromosomes 16 and 19 
Falcaro et al. (2008) used an independent cohort of 93 nuclear families to try to 
replicate the SLIC linkage to chromosomes 16 and 19. They focused on NWR and a 
Past Tense marking trait (PT) but also had data available for ELS. Linkage was 
assessed using the HE method, as described for the SLIC studies, as well as another 
method that is based on the classic DeFries–Fulker approach (DeFries & Fulker, 
1985). The DeFries–Fulker approach is usually applied to twin data to assess the 
heritability of a given trait. It is based on the idea that if a trait is genetically endowed 
then the performance of MZ and DZ co-twins of selected probands will regress to the 
population mean to different extents. The method used by Falcaro et al. (2008) is an 
extension of this algorithm that allows the detection of linkage in sib-pairs, using 
quantitative traits (Fulker et al., 1991), hereafter referred to as the DF-linkage method. 
The DF-linkage method assumes that a sibling’s phenotypic score will regress back to 
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the population mean as a function of environmental and genetic effects (estimated by 
IBD sharing) shared with the proband. The authors found weak linkage with NWR on 
chromosome 16 (maximum LOD score of 1.69, DF-linkage) and significant linkage 
with ELS on chromosome 19 (maximum LOD score of 5.8, DF-linkage). When PT 
was measured as a continuous trait, some linkage was found on both chromosome 16 
(maximum LOD score of 1.8, DF-linkage) and chromosome 19 (maximum LOD 
score of 2.2, DF-linkage). When PT was represented as a binary trait (affected or 
unaffected), linkage was found only on chromosome 19 (maximum LOD score of 
1.66, HE). The authors argue that PT competence is either acquired, or not acquired, 
by a certain age, and it is therefore best analyzed qualitatively. 
A targeted association study of chromosome 16 
Newbury et al. (2009) performed a high density association screen of SLI across the 
chromosome 16 region of linkage using 211 SLIC families. They did a case-control 
analysis (as described previously) and used a family-based quantitative association 
method known as QTDT (Abecasis et al., 2000). QTDT is a regression-based method 
that tests for a significant and consistent correlation between a trait and the number of 
copies of a given marker allele carried by a child (taking into account the expected 
value of this number). For a review of this and similar methods see Ewens et al. 
(2008). The case-control analysis used a binary measure under which cases were 
defined as children with low NWR (>2 SD below the SLIC cohort mean, n=79). 
Controls were defined as children with above-average NWR performance (>0.5 SD 
above population mean, n=71). Only one case or one control was selected from each 
family to maintain independence between cases and controls. Markers falling in the 
CMIP (c-Maf inducing protein, minP=5×10-7) and ATP2C2 (ATPase, Ca++ 
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transporting, type 2C, member 2, minP=2×10-5) genes were significantly associated (P 
< 0.01) with NWR. Both genes are expressed in the brain. ATP2C2 is involved in 
calcium ion transport (Missiaen et al., 2007). Many signaling pathways use calcium as 
a messenger, and calcium regulation is crucial to various nerve cell functions and 
processes (Zheng & Poo, 2007). CMIP interacts with a member of the nuclear factor-
kappaB family of molecules (Kamal et al., 2009), which are involved in synaptic 
activity and plasticity. Alterations of this pathway are found in several nervous system 
diseases, including Alzheimer’s and Parkinson’s (Mémet, 2006). 
The associations with CMIP and ATP2C2 were independent, meaning that both these 
genes could contribute to SLI susceptibility. Both associations were followed up in a 
replication sample, selected from the ALSPAC cohort (Jones et al., 2000) on the basis 
of low language measures (490 cases). ALSPAC is a population study that follows the 
development of ~14,000 children born in the southwest of England between 1991 and 
1992. The same association techniques were applied but the case-control analyses 
used different case/control cut-offs, due to differences in the distributions of NWR 
between SLIC and ALSPAC. Regression trends for markers in ATP2C2 were 
significant (P < 0.05) in the replication sample and replicated those observed by SLIC 
(minP=0.0058). However, the association with CMIP, although significant 
(minP=0.0182), was in the opposite direction, i.e., the marker alleles associated with 
high NWR scores in SLIC were associated with low NWR scores in the replication 
cohort. This could reflect differences in the relationship between the markers and the 
causal variant in the two populations (Lin et al., 2007), but may also indicate that this 
association is a false positive. The authors also investigated the relationship between 
ATP2C2 and CMIP markers and NWR performance in the general population 
(n=3612) using the entire ALSPAC cohort (Jones et al., 2000), but found no evidence 
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for association. They suggest that these two genes affect NWR only in language-
impaired individuals. 
Extended-pedigree studies 
The SLIC studies used small nuclear families. However, linkage studies traditionally 
use extended pedigrees, in which multiple affected individuals provide increased 
power to identify chromosome regions that segregate with a disease. Following this 
strategy, Bartlett et al. (2002) performed a linkage screen of five Canadian SLI 
families, two nuclear and three extended (86 individuals). 
These families were identified during a linkage study of schizophrenia, when many 
individuals were noted to have severe language or reading deficits (Brzustowicz et al., 
2000). Seven individuals in the SLI study were schizophrenic, but the largest pedigree 
(34 individuals) was connected to a schizophrenia family only by marriage. Thus, the 
authors hypothesize that these subjects should not influence the identification of SLI 
susceptibility loci. 
73 subjects were assessed using several tests, including: an age-appropriate version of 
the Test of Language Development (TOLD), an age-appropriate Wechsler 
Intelligence Test and the Token Test, subtests from the Woodcock Reading Mastery 
Test and the Oral Speech Mechanism Screening Examination, and self- or parental-
report questionnaires to assess history of hearing problems. Each family included at 
least two language-impaired individuals, with Spoken Language Quotient Standard 
Score (SLQ), taken from the TOLD, of >1SD below expected, PIQ of ≥80 and PIQ ≥ 
SLQ. Three binary diagnoses were derived for all family members: language 
impairment (SLQ ≤85); reading impairment (single non-word reading score of >1SD 
below PIQ); clinical impairment (language or reading impairment or a self-reported 
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history of language difficulties or dyslexia). These diagnoses were not mutually 
exclusive. 
Parametric linkage analyses were performed under two separate models, assuming 
either dominant or recessive inheritance, for each diagnostic category, giving a total 
of six analyses. The highest LOD scores were further characterized with a Bayesian 
statistical tool, called Posterior Probability of Linkage (PPL). PPL adjusts for the 
structure of the dataset in hand and allows for different effects between individuals 
(Vieland et al., 2001). It is therefore particularly suited to the study of complex 
disorders and provides an increased sensitivity to detect false positives. PPL values 
range from 0 to 1, but are commonly reported as percentages, which can be 
interpreted as the probability that a trait gene is present within the chromosome 
region, linked to a marker. 
Significant evidence of linkage was found on chromosome 13 (LOD=3.92, recessive, 
reading). The maximum PPL was 0.53, suggesting a 53% chance that a risk factor for 
SLI falls in this region. Suggestive evidence for linkage was also detected on 
chromosomes 2 (LOD=2.79, recessive, language) and 17 (LOD=2.19, dominant, 
reading) with maximum PPL values of 5.8% and 3.6%, respectively. No linkage was 
found on chromosomes 16 or 19, in contrast to the results obtained by SLIC. 
Further evidence for linkage to chromosome 13 
Bartlett et al. (2004) added 22 nuclear and extended families (279 individuals from 
the United States) to their previous sample, in a targeted replication of chromosome 
13. In this study, they also investigated chromosomes 2 and 7, which had previously 
been implicated in autism. The assessment tools, criteria for diagnosis and model 
parameters were the same as those described above. Both sample sets were combined 
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for PPL analysis, and an additional linkage method known as the heterogeneity LOD 
score method (HLOD) was used. The HLOD takes into account the fact that several 
loci can contribute to a complex disorder. Two HLOD variants were generated: 
HLOD-P, which is calculated from pooled datasets, and HLOD-S, which calculates 
HLOD scores for each sample separately and then sums them across datasets. 
Weak evidence for linkage to chromosomes 2 and 7 was observed, but chromosome 
13 yielded evidence of linkage in each separate sample set (US sample HLOD=2.616, 
PPL=16.8%; Canadian sample HLOD=3.565, PPL=54.2%) and in the combined 
sample (HLOD-P=6.031; HLOD-S=6.181, PPL=92.3%), under the recessive reading 
impairment model. This region has been designated SLI3. 
Robinson Crusoe Island study 
Extended pedigrees were also used in the unique case of the Robinson Crusoe Island 
population (Villanueva et al., 2011). The Robinson Crusoe Island is located 677 km 
west of Chile and is the only inhabited island in the Juan Fernández archipelago, with 
633 residents (based on the 2002 Chilean census). The island was colonized in the late 
19th century by eight families, and 77% of the current population have a colonizing 
surname (Villanueva et al., 2008). The prevalence of SLI among island children 
related to one of the founder families is very high (35%), compared to that among 
children who are not (3.8%), the latter being close to that reported in mainland Chile 
(4%) (Villanueva et al., 2008). Given the structure of this population, Villanueva et al. 
(2011) hypothesized that the disorder on the island could be the result of a mutation in 
a single gene. They performed non-parametric and parametric (under different 
models) linkage analyses. Several chromosome regions (on chromosomes 6, 7, 12, 13 
and 17) reached genome-wide significance. No linkage to chromosomes 16 or 19 was 
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observed, but the region on chromosome 13 was close to SLI3. The most consistently 
linked region across analyses was a 48 Mb (megabases, i.e. 1000000 base pairs of 
DNA) region on chromosome 7. This overlaps with a chromosome region that has 
been linked to autism and contains several interesting candidate genes, including 
FOXP2 and CNTNAP2, discussed in more detail below. Further studies involving 
additional markers will be required to ascertain which of the genes in this region 
contribute to the language disorder on the island. 
A comparison between the different linkage studies of SLI 
The linkage studies described above differ in several ways. SLIC performed non-
parametric analyses, which do not require a specification of a model, using nuclear 
families; the Bartlett studies applied a parametric approach to a small number of large 
families, and the Robinson Crusoe study used both parametric and non-parametric 
methods with an extremely large pedigree. Each approach has advantages and 
disadvantages, and these design differences may explain much of the lack of overlap 
in results. Parametric models provide increased power, if the model parameters are 
correctly specified. Although mis-specification of parameters can lead to false 
positives, previous studies (Greenberg et al., 1998; Abreu et al., 1999) have 
demonstrated that parametric analyses have sufficient power to detect genomic 
regions linked to complex disorders. Non-parametric methods are affected by the 
distribution of marker allele frequencies and the traits. Discrepant results may also 
reflect the way in which traits are measured, especially for disorders such as SLI, 
which has no standardized diagnostic criteria. Bartlett and Villanueva used binary 
categories of language impairment by applying an arbitrary threshold for affection. 
SLIC considered a continuous distribution of language abilities using standard scores, 
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calibrated against the general population. Three quantitative traits (ELS, RLS and 
NWR), with strong genetic components, were used. Thus, it is possible that these 
alternative aspects of language are under the influence of different genes. The linkage 
regions on chromosomes 16 and 19 (SLIC, 2002) were linked to NWR and ELS, 
respectively, while chromosome 7 (Villanueva et al., 2011) was linked to language 
impairment, and chromosome 13 (Bartlett et al., 2002) was linked to reading 
impairment. Reading impairment was not interpreted as a dyslexia phenotype, but as a 
consequence of language deficits, since failure in phonological processing is often 
observed in SLI (Bishop & Snowling, 2004). These studies indicate that the 
investigation of alternative traits may be useful in dissecting the genetic susceptibility 
in SLI.  
Comorbidity of SLI with other neurodevelopmental disorders 
In SLI, language impairment occurs as a specific phenotype, in the absence of any 
explanatory medical conditions. Nevertheless, delayed language and deficits in 
communication are often present in developmental conditions with a strong genetic 
component, including Autism Spectrum Disorders (ASDs) and Attention Deficit 
Hyperactivity Disorder (ADHD). 
ASDs are a group of neurodevelopmental disorders, autism being the most severe 
form. Family studies suggest that ASDs can be dissected into three heritable, 
potentially distinct, core components (social interaction, language, and repetitive 
behavior), or ‘endophenotypes’, determined in a genetically complex manner. 
In autism, language abilities can be extremely varied. About 50% of autistic children 
do not develop any verbal language and others usually show a delayed development 
of spoken language. The most evident linguistic deficit in autistic individuals is an 
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inappropriate use of language, but structural aspects (phonology and syntax) can be 
affected, in a way similar to that in SLI (e.g. Bishop, 2003; Tager-Flusberg & Joseph, 
2003; Rapin & Dunn, 2003). First and second-degree relatives of autistic patients 
display a higher prevalence of language impairment than the general population. 
These similarities have stirred a debate regarding the diagnostic boundaries between 
SLI and ASD (as reviewed by Taylor et al., 2012) leading to the hypothesis that SLI 
and autism might share some genetic susceptibility factors. The alternative hypothesis 
argues that differing patterns of linguistic performance may reflect alternative, distinct 
causes. 
Genetic overlaps between SLI and autism 
Several whole-genome linkage studies have been performed for autism, but replicated 
regions between samples are rare. The most consistently linked loci are on 
chromosomes 2 (designated AUTS5) and 7 (designated AUTS1) (IMGSAC 1998, 
IMGSAC 2001). A possible strategy to understand the divergence at both the 
phenotypic and genetic levels and to increase the chances of identifying contributory 
genetic variants is the study of single endophenotypes. 
One study focusing on language-related endophenotypes in autism (Bradford et al., 
2001) found linkage to chromosomes 7 and 13, the latter overlapping with that 
identified by Bartlett et al. (2002) in SLI families. Both signals were strongest in 
families with ASD probands with Phrase Speech Delay (PSD) beyond 36 months of 
age, and parents with a history of language difficulties. In another ASD linkage 
screen, three endophenotypes from the Autism Diagnostic Interview (ADI) were 
examined: "age at first word", "age at first phrase" and "repetitive and stereotyped 
behavior" (Alarcón et al., 2002). The strongest evidence of linkage was obtained for 
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"age at first word", on chromosome 7, close to that reported by IMGSAC (1998). 
The other main linkage locus found by the IMGSAC (2001), on chromosome 2, has 
also been studied in specific categories of autism sub-phenotypes. One study 
(Buxbaum et al., 2001), found that linkage in this region was strongest in families 
which included two or more autistic children with PSD beyond 36 months of age. 
Subsequently, Shao et al. (2002) also detected an increase in linkage signals on 
chromosome 2, when they stratified their sample by PSD. Note, however, that this 
region has not been implicated in SLI studies. This does not exclude the possibility 
that this locus harbors a risk factor for language impairment, but may instead reflect 
the different language categories used in other disorders.  
The chromosome 19 locus, found to be linked to ELS in the SLIC study (2002), also 
overlaps with an autism linkage region (Liu et al., 2001). This linkage was driven by a 
strictly-defined group of autistic families, in which the probands had impairments in 
all three core domains, and an age at onset of <3 years. One would expect that the 
greatest overlap with SLI would be found in the less severely affected families. 
However, these families include Asperger patients, who are characterized by 
relatively high linguistic capabilities. Thus, it remains possible that variants that 
contribute to susceptibility to SLI and autism may be found on chromosome 19. 
More recently, linkage studies with higher resolution and larger cohorts of ASD 
families (AGP et al., 2007; Weiss et al., 2009) have been carried out, but the linkage 
regions described above did not reach genome-wide significance. In the study realized 
by the Autism Genome Project (AGP, 2007), in order to create more homogeneous 
categories, the samples were stratified in categories, but, even in these subsets, the 
loci on 7q and 2q reached only suggestive evidence of linkage, confirming the genetic 
heterogeneity underlying the ASDs. Genome-wide association studies (Weiss et al., 
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2009; Wang et al., 2009, Anney et al., 2010) have been also carried out for autism, but 
the common variants identified explain only a small fraction of the genetic heritability 
of this disorder. On the other hand, a growing body of evidence suggests that genetic 
contribution to ASDs includes de novo or rare inherited variants of intermediate-high 
penetrance (as reviewed by Devlin & Scherer, 2012). 
Recent high-throughput CNV screenings and exome-sequencing studies have begun 
to uncover a large number of individually rare variants, sequence mutations and 
structural rearrangements (CNVs, explained in the next section), that might contribute 
to ASDs, implicating hundreds of autism risk genes (Devlin & Scherer, 2012). The 
next challenge will be establishing which of the potentially deleterious variants 
actually play a role in the disease: investigating whether they affect genes involved in 
interconnected pathways that influence synaptogenesis and related biological 
processes, will narrow down the list of candidate genes and clarify the molecular 
mechanisms impaired in ASDs. 
Exome-sequencing or CNV studies for SLI have not been published yet, but these 
kind of studies will help to elucidate the genetic architecture of SLI, establishing the 
contribution of rare variants and structural rearrangements and determining the genes 
involved in the disorder. Network analyses might provide new evidence of potential 
genetic overlaps between SLI and other neurodevelopmental conditions like ASDs.  
Copy Number Variants (CNVs) 
It has recently been shown that a large part of human variation does not involve 
changes to the genetic sequence per se, but rather structural rearrangements or 
submicroscopic copy number variations (CNVs) (Sebat et al., 2004; Redon et al., 
2006). CNVs can involve the loss (deletions) or gain (duplications) of DNA segments 
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or can be more complex. They can be inherited from a parent or may be de novo if 
they originate in the parent germ line or during early fetal development. CNVs can 
directly disrupt genes or regulatory elements, or alter the number of gene copies, 
leading to phenotypic consequences. However, CNVs affecting the same gene are 
associated with different disorders and found in unaffected individuals (as reviewed 
by Cook & Scherer, 2008). Presumably, some events may have lower impact due to 
their location in the gene or their consequences may be modified by additional genetic 
variants, or genetic background. Although they are not yet fully understood, the study 
of CNVs has helped to highlight biologically relevant genetic pathways in 
neurodevelopmental disorders. They play an important role in susceptibility to many 
complex disorders, including: autism, schizophrenia and ADHD (Cook & Scherer, 
2008). 
An example of potential genetic overlap between autism and SLI given by CNVs can 
be found in a study of sporadic autistic trios, (i.e. mother, father and proband from a 
family in which the parents and siblings are all unaffected), where a deletion in 
ATP2C2, a candidate gene for SLI discussed in a previous section, was found in an 
autistic child. However, this reported deletion was inherited from an unaffected 
mother (O'Roak et al., 2012). Similarly, a de novo deletion of two genes on 
chromosome 16, including the SLI candidate gene CMIP, was identified in an autistic 
child with severe receptive and expressive language deficits (Van der Aa et al., 2012). 
Genetic overlap between SLI and ADHD 
ADHD is a common childhood neuropsychiatric disorder, characterized by a triad of 
impairments (inappropriate inattentiveness, increased impulsivity, and hyperactivity), 
(DSM IV-TR - (American Psychiatric Association (APA) 2000)). Although ADHD is 
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highly variable among individuals, patients often have deficits in executive and self-
regulatory functions, such as: temporal organization, holding and manipulating 
information, which require working memory (Barkley, 1997) and often exhibit 
language impairments (Tirosh & Cohen, 1998). 
Genome wide association studies of ADHD (Neale et al., 2008; Mick et al., 2010; 
Neale et al., 2010; Stergiakouli et al., 2012) have failed to detect statistically 
significant association results for any SNP. However, sub-threshold signals might 
indicate potentially relevant loci. A GWAS of ADHD (Lesch et al., 2008) detected 
association with ATP2C2 (P=8 x 10-7), among the top 30 markers located in gene 
regions. Interestingly, considering the fact that the SLIC ATP2C2 association was 
with NWR, studies report that reduced performance in working memory tasks are 
correlated with verbal deficits in children with ADHD (Cohen et al., 2000). Therefore, 
impairments in working memory have been proposed as a shared mechanism between 
ADHD and SLI. The SLIC studies did not exclude individuals with ADHD, and a 
high proportion of their samples were predicted to have ADHD, developmental 
coordination disorder, or reading problems (Newbury et al., 2009). The causal 
variants in ATP2C2 have yet to be identified, but these findings support the idea that 
ATP2C2 may be involved in neurological processes important for phonological short-
term memory and may be relevant to developmental disorders that involve working 
memory deficits, such as SLI and ADHD. 
Genetic pathways 
There is a growing body of evidence that shared or related genetic mechanisms exist 
between disorders such as SLI, autism and ADHD. Given this, researchers have 
begun studying genetic risk factors at the level of the biological pathway rather than 
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specific candidate genes. Under this hypothesis, related neurodevelopmental disorders 
are caused by combinations of genetic risk variants across overlapping pathways that 
serve the developmental mechanisms important for brain development. Support for 
this hypothesis has been largely driven by investigations into autism and learning 
disability, and by studies of biological pathways mediated by FOXP2 (Fisher & 
Scharff, 2009). 
FOXP2 and CNTNAP2 
Mutations disrupting FOXP2 cause a rare and severe speech and language disorder 
(Lai et al., 2001). The FOXP2 gene encodes a transcription factor protein which 
regulates the expression of other genes (referred to as its targets) by binding to 
specific DNA sequences in their regulatory regions. FOXP2 regulates hundreds of 
genes, many of which are known to be important during brain development (Vernes et 
al., 2007; Spiteri et al., 2007). One such gene is called CNTNAP2, which codes for a 
protein called CASPR2 and is found on chromosome 7 (Vernes et al., 2008). The 
CASPR2 protein belongs to the neurexin family, whose members establish 
interactions between brain cells during nervous system development. In the human 
fetal brain, CNTNAP2 has an unusual enrichment in regions that are important for 
language e.g., the prefrontal cortex (Abrahams et al., 2007). Levels of CNTNAP2 are 
highest at low FOXP2 levels and vice versa, indicating that FOXP2 negatively 
regulates CNTNAP2. 
Variants in FOXP2 itself are not thought to contribute to SLI (Newbury et al., 2002), 
but markers in CNTNAP2 have been shown to be associated with language 
impairment. 184 SLIC families were used in a quantitative association analysis with 
ELS, RLS and NWR (Vernes et al., 2008). Several markers showed association, 
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primarily to NWR (minP=5×10-5) and, to a lesser extent, to RLS (minP=0.003) and 
ELS (minP=0.008). Markers in CNTNAP2 have also been associated with 
endophenotypes of early language development in the general population 
(minP=0.0239) (Whitehouse et al., 2011) and with "age at first word" in an autistic 
cohort (minP=0.002) (Alarcón et al., 2008). Complex chromosomal rearrangements 
and CNVs, in particular deletions, involving CNTNAP2, have also been reported in 
studies of other neurodevelopmental disorders including autism (Bakkaloglu et al., 
2008; Poot et al., 2010), stuttering (Petrin et al., 2010), ADHD (Elia et al., 2010), 
Tourette’s syndrome (Verkerk et al., 2003), schizophrenia and epilepsy (Friedman et 
al., 2008, Sehested et al., 2010) and mental retardation (Zweier et al., 2009), 
supporting the idea of shared pathways between related disorders. The conditions 
related to CNTNAP2 mutations are numerous and variable, but they present a certain 
degree of comorbidity, perhaps representing shared or intersected neuronal 
mechanisms that converge on common genes like CNTNAP2. 
A loss-of-function mutation, which is predicted to prevent the production of 
functional CNTNAP2 protein, was found in children from an isolated population (Old 
Order Amish), affected by a syndrome associated with ASDs, called Cortical 
Dysplasia-Focal Epilepsy syndrome (CDFE) (Strauss et al., 2006). Screening of non-
syndromic ASD patients also found mutations which altered the sequence of 
CNTNAP2, but did not prevent the production of the protein (Bakkaloglu et al., 2008). 
These changes were not present in controls, but were always inherited from an 
apparently unaffected parent. Thus, as discussed with regards to CNVs above, it is 
likely that some alterations of CNTNAP2 may need to occur in conjunction with 
mutations in related genes to cause neurological dysfunction. The outcome is likely to 
be determined by the molecular pathways affected and the genetic and environmental 
The Genetics of SLI  Nudel, Ceroni, Simpson & Newbury 
23 
 
backgrounds of subjects. A recent exome-sequencing study identified a CNTNAP2 
mutation that is predicted to be damaging in an autistic child, which supports this 
hypothesis (O’Roak et al., 2011). In this study, the mutation was inherited from the 
mother, and was present in an unaffected sister. The exome sequence of the proband, 
who was severely affected with regression, language delay, moderate intellectual 
disability, revealed an additional deleterious mutation in FOXP1 that was absent in 
the rest of the family (O’Roak et al., 2011). Further experiments are required to 
clarify the role of FOXP1, but it is known to be closely related to FOXP2, and has 
been implicated in speech and language impairments and intellectual disability 
(reviewed by Bacon & Rappold, 2012). Furthermore, like FOXP2, the expression 
levels of FOXP1 are inversely correlated with those of CNTNAP2 (O’Roak et al., 
2011). 
Taken together, these findings support the hypothesis of a widespread effect of 
CNTNAP2. New technologies and the falling costs of high-throughput sequencing 
mean that the identification of similar candidate genes will become increasingly more 
common.  
Conclusions 
SLI is a complex disorder with a strong genetic component. Therefore, the study of 
the genetics of SLI can complement SLI research done in other disciplines: behavioral 
studies of SLI are important in order to better characterize the disorder itself and find 
differences between and similarities with other developmental disorders. Genetic 
studies of SLI require good classifications of disease status and/or appropriate 
(linguistic) measures in order to be meaningful (see Figure 1). When those are 
available, genetic studies may find similarities between disorders at a molecular level, 
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which otherwise might not have been discovered. Recent studies have allowed the 
identification of several genes that may be involved in SLI, and, indeed, some of these 
genes have also been implicated in other neurodevelopmental disorders in which 
language may be impaired, such as ASD and ADHD. We believe that a good choice 
of endophenotypes and the application of new technologies hold the key to 
understanding the genetic basis of SLI. Emerging links between comorbid 
developmental disorders suggest the existence of overlapping biological pathways. 
Researchers continue to study these genes and biological pathways in an attempt to 
further elucidate the molecular mechanisms that are impaired in SLI and related 
disorders. 
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